Moderna Inc (MRNA)

Exchange
NASDAQ
Symbol
MRNA
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    38.21
  • High
    38.65
  • Low
    35.93
  • Close
    36.55
  • Volume
    13,511,800

Financial ratios

Dec 31, 2023